Cosmos Health 获得 Taglich Brothers 的 4 美元目标价，表明潜在增长。 
Cosmos Health receives $4 stock price target from Taglich Brothers, indicating potential growth.
科斯莫斯健康公司 (COSM) 收到了泰格利希兄弟的4美元股价目标,反映了该公司扩大为垂直整合的全球健康组织的显著增长潜力. Cosmos Health Inc. (COSM) has received a $4 stock price target from Taglich Brothers, reflecting significant growth potential as the company expands into a vertically integrated global health organization. 公司预测,2024财政年度的收入为5 630万美元,在2025财政年度增长22.6%,达到6 900万美元,预期有业务利润和现金收入。 The firm forecasts FY2024 revenue of $56.3 million, rising 22.6% to $69 million in FY2025, with anticipated operating profit and cash earnings. CEO Greg Siokas支持这个目标, CEO Greg Siokas supports the target, citing strategic investments driving growth.
